Tariffs or not, a Chinese baby products company is ramping up its U.S. expansion
Summary by CNBC
8 Articles
8 Articles
All
Left
1
Center
1
Right
How a U.S. Pharma Leader Tackled Tariff Risks Head-On With GEP’s Help
How a U.S. Pharma Leader Tackled Tariff Risks Head-On With GEP’s Help priyanka.katke… Tue, 05/20/2025 - 22:27 With a large supply base in high-tariff countries and no clarity on how suppliers would pass on costs, a U.S. pharmaceutical company knew it had to take urgent, pre-emptive action.It brought in GEP to take a hard look at its $12 billion in spend, uncover vulnerabilities and manage tariff risk.See how GEP identified over $3 billion expose…
Coverage Details
Total News Sources8
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage